SGLT-2抑制剂对糖尿病肾病影响的研究进展(4)
[13] MATTHAEI S，BOWERING K，ROHWEDDER K，et al.Durability and tolerability of dapagliflozin over 52？偆f weeks as add-on to metformin and sulphonylurea in type 2 diabetes[J].Diabetes Obes Metab，2015，17(11)：1075-1084.[14] XU L，OTA T.Emerging roles of SGLT2 inhibitors in obesity and insulin resistance： Focus on fat browning and macrophage polarization[J].Adipocyte ......
您现在查看是摘要页，全文长 2648 字符。